GlycoMimetics

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell GlycoMimetics and other ETFs, options, and stocks.

About GLYC

GlycoMimetics, Inc. is a biotechnology company, which engages in the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in which carbohydrate biology plays a key role. The company was founded by Rachel K.

CEO

Harout Semerjian, MBA

CEOHarout Semerjian, MBA

Employees

Employees26

Headquarters

Rockville, Maryland

HeadquartersRockville, Maryland

Founded

2003

Founded2003

Employees

Employees26

GLYC Key Statistics

Market cap

16.83M

Market cap16.83M

Price-Earnings ratio

-0.44

Price-Earnings ratio-0.44

Dividend yield

—

Dividend yield—

Average volume

636.76K

Average volume636.76K

High today

$0.275

High today$0.275

Low today

$0.2482

Low today$0.2482

Open price

$0.25

Open price$0.25

Volume

658.33K

Volume658.33K

52 Week high

$1.93

52 Week high$1.93

52 Week low

$0.1406

52 Week low$0.1406

GlycoMimetics

Why Robinhood?

GlycoMimetics, Inc. is a biotechnology company, which engages in the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in which carbohydrate biology plays a key role. The company was founded by Rachel K. Show more

GLYC Key Statistics

GlycoMimetics, Inc. is a biotechnology company, which engages in the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in which carbohydrate biology plays a key role. The company was founded by Rachel K.